Umbrellux DAO Saves Summer Happy Hours From Being Spoiled

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
13
Umbrellux DAO Saves Summer Happy Hours From Being Spoiled

ANN ARBOR, Mich., May 23, 2018 (GLOBE NEWSWIRE) -- Beer and wine are staples for summer fare at picnics, ballparks and boardwalks, but for some people these happy hour drinks may immediately trigger unpleasant problems like flushing, dizziness, fatigue, nausea and headaches. While a hangover might be the first to blame, symptoms that begin within 15 minutes of sipping these alcoholic beverages could indicate the real issue is histamine intolerance brought on by a DAO enzyme deficiency. Happy hour can easily be remedied by first taking an Umbrellux DAO enzyme prior to partaking in these high-histamine alcoholic beverages.

“Few people are aware of histamine intolerance but it’s actually very similar to lactose intolerance associated with dairy, in that your body lacks the enzyme to breakdown certain foods and beverages that are high in histamine” said Felicia Stoler, registered dietician, nutritionist and author. “Histamine is a chemical that is present in a variety of fermented food and drinks such as beer, wine and aged cheese. If your body is not producing enough of the DAO enzyme, it will have trouble breaking down and processing these foods and beverages.”

Histamine intolerance is poorly understood in the medical world and diagnoses can put a damper on summer celebrations as you try to determine if you are deficient in this enzyme. Normal levels of plasma histamine range from 0.3-1.0 ng/ml, but anything above this could cause problems. Diamine oxidase, or DAO enzymes can dramatically improve symptoms and allow you to enjoy high-histamine foods and beverages. 

Since there is not a good test to measure histamine or DAO levels, Stoler suggests taking Umbrellux DAO before partaking in wine and beer as an easy way to see if symptoms are related to DAO deficiency and histamine intolerance. She also recommends trying wines with lower histamine counts such as white, sparkling and rosé wines, which are all lower in histamine compared to red wines that can have 20-200 percent more histamine. Drinking a cup of black tea before your wine or beer can also help as it has a histamine-reducing effect.

It is recommended to take Umbrellux DAO 15-20 minutes before a meal or beverage, or as directed by your doctor. It may be taken daily to maintain long-term balance of DAO in your body. It also contains vitamin C (abscorbic acid), which is required for DAO activity. Umbrellux DAO is the only food-grade DAO enzyme currently licensed and sold in the United States outside of doctors’ offices and can be purchased directly online at www.umbrelluxdao.com .

Women may be more affected by DAO deficiency than men as histamine levels are elevated during menstruation. Age can also be a factor. Changes to the digestive system as a person ages can leave them deficient in the enzyme that breaks down gastric histamine and therefore make them more vulnerable to histamine reactions. Certain medications can also interfere with DAO enzyme activity. For more information on DAO deficiencies, visit: www.daodeficiency.org .

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...5d09b1adcc

Media Contact: Amy Summers 212-757-3419 or   Pitch Publicity

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 119

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 411

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 378

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 0

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 585

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 481

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 259

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 407

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Dollar Tree's Earnings Drop and Future Outlook Challenges

Updated Category News Views 123

Highlights from Dollar Tree's Earnings Report Dollar Tree has encountered significant challenges in the market after revealing that its second-quarter earnings did not meet analysts' expectations. The discount retailer reported a year-over-year decline in net income, attributing this downturn to the considerable difficulties posed by the current economic conditions. This...

Continue Reading
The Risks of Banking Standards: A Deep Dive into Safety

Updated Category News Views 411

Understanding Current Banking Risks Banks are integral to the economy, ensuring that funds flow smoothly throughout various sectors. However, recent decisions to relax standards for banks have raised significant concerns about potential risks that may arise. Weiss Ratings, a prominent name in independent bank safety evaluations, has recently highlighted unsettling changes...

Continue Reading
Koch and OCP Forge Ahead with New Joint Venture

Updated Category News Views 46

Tying Two Giants Together When industrial titans like Koch Ag & Energy Solutions and Moroccan powerhouse OCP decide to double down on their existing partnership, anyone with a stake in iron and fertilizer industries ought to take note. It's not every day that two behemoth corporations decide to lace up together in a joint venture, signaling a potential shift in market...

Continue Reading
Youlife Group Inc. Moves to Expand with Strategic Acquisitions

Updated Category News Views 213

Youlife Group Inc. Expands Market Reach with Key Acquisitions Youlife Group Inc. (NASDAQ: YOU), recognized as a leading provider of blue-collar lifetime services, has exciting plans to make strategic acquisitions aimed at bolstering its market position. This initiative comes as Youlife enters into non-binding term sheets with the controlling shareholders of four notable...

Continue Reading
Advancements in Wet AMD Treatment: Outlook Therapeutics Updates

Updated Category News Views 326

Significant Milestones for Outlook Therapeutics ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pioneering biopharmaceutical company, has made notable strides towards securing regulatory approval for its innovative treatment for wet age-related macular degeneration (wet AMD). Their investigational product, ONS-5010 (bevacizumab-vikg), is an ophthalmic...

Continue Reading